Reuters CureVac, a German-based biotechnology company, jumped $ 213.3 million and more than a third of its IPO price in its initial public offering on Friday. Shares of the company have continued to grow since its Friday IPO, gaining as much as 52% to $ 85 per share on Monday …
Read More »Report: US investigates possibility of controversial ‘challenge test’ for COVID-19 vaccine
Federal health officials have begun preliminary work to establish protocols for a “challenge” trial of a COVID-19 vaccine, including creating a strain of the virus that could be used. Reuters reported it on Friday. A ‘challenge test’ is a controversial idea to deliberately infect a few hundred young, healthy volunteers …
Read More »What does our smart money tell us?
Stock market display screenshot on the street with stock market crash sell-off in red … [+] color getty The US stock market has been flirting with record highs this week, and this has caused a lot of nerves among investors. One of the reasons stock traders have been feeling jittery …
Read More »Russia offered help with vaccine against coronavirus, US denied: report
Russia offered to help US with coronavirus vaccine, but US refused, Russian officials told CNN Thursday. Russian officials told the network they were proposing “unusual cooperation” with US Operation Warp Speed, the initiative to develop a COVID-19 vaccine. But Russian officials said the “US is not currently open” for its …
Read More »Andrew Lloyd Webber puts his money where his mouth is
(News) – Andrew Lloyd Webber is worried about getting audiences back to the theater, which is why he is now participating in a trial with coronavirus vaccines from Oxford University and pharmaceutical company AstraZeneca. “I’m excited to be vaccinated tomorrow for the Oxford Covid 19 trial,” the composer said on …
Read More »